Quoin Pharmaceuticals
(NASDAQ) QNRX
Quoin Pharmaceuticals Financials at a Glance
Market Cap
$8.60M
Revenue (TTM)
$0.00
Net Income (TTM)
$15.80B
EPS (TTM)
$-460.50
P/E Ratio
-0.01
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$5.74
Volume
31,836
Open
$5.94
Price
$5.74
Volume
31,836
Open
$5.94
Previous Close
$5.74
Daily Range
$5.61 - $6.07
52-Week Range
$5.47 - $41.80
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$5.74
Volume
31,836
Open
$5.94
Previous Close
$5.74
Daily Range
$5.61 - $6.07
52-Week Range
$5.47 - $41.80
QNRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quoin Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Michael Myers, PhD
Website
www.quoinpharma.comHeadquarters
Ashburn, VA 20148-7349, US
QNRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-143%
Return on Capital
-1%
Return on Assets
-775%
Earnings Yield
-100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.60M
Shares Outstanding
1.50M
Volume
31.84K
Short Interest
0.00%
Avg. Volume
99.24K
Financials (TTM)
Gross Profit
$100.79K
Operating Income
$16.42M
EBITDA
$16.32M
Operating Cash Flow
$13.54B
Capital Expenditure
$4.00
Free Cash Flow
$13.54B
Cash & ST Invst.
$3.82B
Total Debt
$0.00
Quoin Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$25.16K
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.60M
N/A
Market Cap/Employee
$2.87M
N/A
Employees
3
N/A
Net Income
$15.79B
-683211.4%
EBITDA
$4.70M
-97.3%
Quarterly Fundamentals
Net Cash
$3.82B
+27061.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-775.10%
N/A
Return on Invested Capital
-1.11%
N/A
Free Cash Flow
$5.08M
-127.2%
Operating Cash Flow
$5.08M
-127.2%